Displaying drugs 7776 - 7791 of 7791 in total
Tryptophan
An essential amino acid that is necessary for normal growth in infants and for nitrogen balance in adults. It is a precursor of indole alkaloids in plants. It is a precursor of serotonin (hence its use as an antidepressant and sleep aid). It can be a precursor to niacin, albeit...
Approved
Nutraceutical
Withdrawn
Matched Synonyms: … (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid ... (S)-α-amino-1H-indole-3-propanoic acid …
Matched Iupac: … (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid …
Matched Description: … It can be a precursor to niacin, albeit inefficiently, in mammals. ... It is a precursor of serotonin (hence its use as an antidepressant and sleep aid). ... An essential amino acid that is necessary for normal growth in infants and for nitrogen balance in adults …
Matched Mixtures name: … Aminosyn II and Dextrose ... Aminosyn II and Dextrose ... Olimel 4.4% E …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Matched Products: … Apo-tryptophan …
Matched Iupac: … (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid …
Matched Description: … It can be a precursor to niacin, albeit inefficiently, in mammals. ... It is a precursor of serotonin (hence its use as an antidepressant and sleep aid). ... An essential amino acid that is necessary for normal growth in infants and for nitrogen balance in adults …
Matched Mixtures name: … Aminosyn II and Dextrose ... Aminosyn II and Dextrose ... Olimel 4.4% E …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Matched Products: … Apo-tryptophan …
Viper antivenom
Viper antivenom consists of antibodies derived from horses immunized and subsequently developed antibodies against snake venoms. ANAVIP, an equine-derived antivenom made with venom from Bothrops asper and Crotalus durissus, was first approved by the FDA on October 1, 2015, for the management of North American rattlesnake envenomation.
Approved
Matched Synonyms: … Crotalidae immune F(ab')2 (equine) ... Antivenin crotaline (pit-viper) equine immune F(ab)2) …
Matched Description: … first approved by the FDA on October 1, 2015, for the management of North American rattlesnake envenomation ... ANAVIP, an equine-derived antivenom made with venom from _Bothrops asper_ and _Crotalus durissus_, was ... Viper antivenom consists of antibodies derived from horses immunized and subsequently developed antibodies …
Matched Description: … first approved by the FDA on October 1, 2015, for the management of North American rattlesnake envenomation ... ANAVIP, an equine-derived antivenom made with venom from _Bothrops asper_ and _Crotalus durissus_, was ... Viper antivenom consists of antibodies derived from horses immunized and subsequently developed antibodies …
(2S)-2,3-bis{[(3R,7R)-3,7,11,15-tetramethylhexadecyl]oxy}propyl (2R)-2-hydroxy-3-[(hydroxyphosphinato)oxy]propyl phosphate
Experimental
Matched Name: … (2S)-2,3-bis{[(3R,7R)-3,7,11,15-tetramethylhexadecyl]oxy}propyl (2R)-2-hydroxy-3-[(hydroxyphosphinato …
Matched Iupac: … (3R,7R)-1-{[(2S)-1-({hydroxy[(2R)-2-hydroxy-3-(phosphonooxy)propoxy]phosphoryl}oxy)-3-{[(3R,7R)-3,7,11,15 ... -tetramethylhexadecyl]oxy}propan-2-yl]oxy}-3,7,11,15-tetramethylhexadecane …
Matched Iupac: … (3R,7R)-1-{[(2S)-1-({hydroxy[(2R)-2-hydroxy-3-(phosphonooxy)propoxy]phosphoryl}oxy)-3-{[(3R,7R)-3,7,11,15 ... -tetramethylhexadecyl]oxy}propan-2-yl]oxy}-3,7,11,15-tetramethylhexadecane …
Froniglutide
Glymera is under investigation in clinical trial NCT01658501 (Phase 2b Multicenter, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM).
Investigational
Matched Synonyms: … Glucagon like peptide-1 Elastin like peptide-120 fusion protein …
Matched Description: … , Placebo- and Active-controlled, Parallel-group Study to Assess the PD Response and Safety of Three ... Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM). ... Glymera is under investigation in clinical trial NCT01658501 (Phase 2b Multicenter, Randomized, Double-blind …
Matched Description: … , Placebo- and Active-controlled, Parallel-group Study to Assess the PD Response and Safety of Three ... Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM). ... Glymera is under investigation in clinical trial NCT01658501 (Phase 2b Multicenter, Randomized, Double-blind …
Ciprocinonide
Approved
Investigational
Matched Synonyms: … )bis(oxy))-, (6.alpha.,11.beta.,16.alpha ... Pregna-1,4-diene-3,20-dione, 21-((cyclopropylcarbonyl)oxy)-6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene ... 21-cyclopropanecarboxylate …
Matched Iupac: … 2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo ... [10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-8-yl]-2-oxoethyl cyclopropanecarboxylate …
Matched Iupac: … 2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo ... [10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-8-yl]-2-oxoethyl cyclopropanecarboxylate …
(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE
Experimental
Matched Name: … (2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E …
Matched Iupac: … [(2R)-2,3-dihydroxypropoxy][(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic …
Matched Iupac: … [(2R)-2,3-dihydroxypropoxy][(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propoxy]phosphinic …
(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE
Experimental
Matched Name: … (3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE ... -1,7(8H)-DIONE …
Matched Iupac: … (3R,5Z,8S,9S,11E)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,7,8,9,10-hexahydro-1H-2-benzoxacyclotetradecine ... -1,7-dione …
Matched Iupac: … (3R,5Z,8S,9S,11E)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,7,8,9,10-hexahydro-1H-2-benzoxacyclotetradecine ... -1,7-dione …
N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE
Experimental
Matched Name: … N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10- …
Matched Iupac: … (2R)-N'-hydroxy-2-(2-methylpropyl)-N-[(10S)-9-oxo-1,8-diazatricyclo[10.6.1.0^{13,18}]nonadeca-12(19), ... 13(18),14,16-tetraen-10-yl]butanediamide …
Matched Iupac: … (2R)-N'-hydroxy-2-(2-methylpropyl)-N-[(10S)-9-oxo-1,8-diazatricyclo[10.6.1.0^{13,18}]nonadeca-12(19), ... 13(18),14,16-tetraen-10-yl]butanediamide …
Ergocalciferol
Ergocalciferol is an inactivated vitamin D analog. It is synthesized by some plants in the presence of UVB light. The production of ergocalciferol was prompted by the identification of dietary deficiency, more specifically vitamin D, as the main causative factor for the development of rickets. Ergocalciferol was isolated for the...
Approved
Nutraceutical
Matched Synonyms: … (3β,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol ... (5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol ... (5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol …
Matched Iupac: … (1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden- ... 4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol …
Matched Description: … ] by the presence of a double bond between C22 and C23 and the presence of a methyl group at C24. ... US Pharm Holdings and was FDA approved in 1941. ... Ergocalciferol was isolated for the first time from yeast in 1931 and its structure was elucidated in …
Matched Mixtures name: … Magnum-75 Vitamin and Mineral Supplement ... Cal/mag 2:1 With D ... Mvc 9+4 Inj …
Matched Categories: … Alimentary Tract and Metabolism ... Diet, Food, and Nutrition ... Vitamin D and Analogues ... Calcium-Regulating Hormones and Agents …
Matched Products: … Vitamin D 400 I.U. Tablets …
Matched Iupac: … (1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden- ... 4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol …
Matched Description: … ] by the presence of a double bond between C22 and C23 and the presence of a methyl group at C24. ... US Pharm Holdings and was FDA approved in 1941. ... Ergocalciferol was isolated for the first time from yeast in 1931 and its structure was elucidated in …
Matched Mixtures name: … Magnum-75 Vitamin and Mineral Supplement ... Cal/mag 2:1 With D ... Mvc 9+4 Inj …
Matched Categories: … Alimentary Tract and Metabolism ... Diet, Food, and Nutrition ... Vitamin D and Analogues ... Calcium-Regulating Hormones and Agents …
Matched Products: … Vitamin D 400 I.U. Tablets …
Linoleic acid
Approved
Experimental
Matched Synonyms: … C18:2 9c, 12c omega6 todos cis-9,12-octadienoico ... all-cis-9,12-octadecadienoic acid ... (9Z,12Z)-Octadecadienoic acid …
Matched Iupac: … (9Z,12Z)-octadeca-9,12-dienoic acid …
Matched Salts cas: … 822-17-3 …
Matched Mixtures name: … Bio-efa Borage Gla 240 Cap ... Bio-efa Borage Gla 90 Cap ... Virt-Care One …
Matched Iupac: … (9Z,12Z)-octadeca-9,12-dienoic acid …
Matched Salts cas: … 822-17-3 …
Matched Mixtures name: … Bio-efa Borage Gla 240 Cap ... Bio-efa Borage Gla 90 Cap ... Virt-Care One …
Thalidomide
A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, thalidomide was withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of inflammatory disorders and cancers. Thalidomide displays immunosuppressive and anti-angiogenic activity through modulating the release of inflammatory mediators like tumor necrosis factor-alpha...
Approved
Investigational
Withdrawn
Matched International brands: … Pro-ban M ... K-17 …
Matched Synonyms: … 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline ... 2,6-dioxo-3-phthalimidopiperidine ... (+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide …
Matched Iupac: … 2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione …
Matched Description: … Due to severe teratogenicity, pregnancy must be excluded before the start of treatment and patients must ... It has been reintroduced and used for a number of inflammatory disorders and cancers. ... inflammatory mediators like tumor necrosis factor-alpha (TNF-a) and other cytokine action. …
Matched Categories: … Antineoplastic and Immunomodulating Agents ... Heterocyclic Compounds, 1-Ring ... Heterocyclic Compounds, 2-Ring ... Cytochrome P-450 CYP2B6 Inducers ... Cytochrome P-450 Substrates …
Matched Products: … THALIDOMIDE CELGENE 50 MG SERT KAPSUL, 28 ADET ... TALIDOMIDE BMS ... INMUNOPRIN® 100 MG COMPRIMIDOS RECUBIERTOS …
Matched Synonyms: … 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline ... 2,6-dioxo-3-phthalimidopiperidine ... (+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide …
Matched Iupac: … 2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione …
Matched Description: … Due to severe teratogenicity, pregnancy must be excluded before the start of treatment and patients must ... It has been reintroduced and used for a number of inflammatory disorders and cancers. ... inflammatory mediators like tumor necrosis factor-alpha (TNF-a) and other cytokine action. …
Matched Categories: … Antineoplastic and Immunomodulating Agents ... Heterocyclic Compounds, 1-Ring ... Heterocyclic Compounds, 2-Ring ... Cytochrome P-450 CYP2B6 Inducers ... Cytochrome P-450 Substrates …
Matched Products: … THALIDOMIDE CELGENE 50 MG SERT KAPSUL, 28 ADET ... TALIDOMIDE BMS ... INMUNOPRIN® 100 MG COMPRIMIDOS RECUBIERTOS …
(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate
Experimental
Matched Name: … (4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho ... [2,1-f]isoquinolin-8-yl sulfamate …
Matched Iupac: … (4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-[(pyridin-3-yl)methyl]-1H,2H,3H,4H,4aH,4bH,5H,6H,10bH,11H, ... 12H,12aH-naphtho[2,1-f]isoquinolin-8-yl sulfamate …
Matched Iupac: … (4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-[(pyridin-3-yl)methyl]-1H,2H,3H,4H,4aH,4bH,5H,6H,10bH,11H, ... 12H,12aH-naphtho[2,1-f]isoquinolin-8-yl sulfamate …
Metformin
Metformin is a biguanide antihyperglycemic agent and first-line pharmacotherapy used in the management of type II diabetes.[L12207,A176173]
Metformin is considered an antihyperglycemic drug because it lowers blood glucose concentrations in type II diabetes without causing hypoglycemia. It is commonly described as an "insulin sensitizer", leading to a decrease in insulin...
Approved
Matched International brands: … Apo-Metformin …
Matched Synonyms: … 1,1-Dimethylbiguanide …
Matched Iupac: … 1-carbamimidamido-N,N-dimethylmethanimidamide …
Matched Description: … It is commonly described as an "insulin sensitizer", leading to a decrease in insulin resistance and ... Metformin is a biguanide antihyperglycemic agent and first-line pharmacotherapy used in the management ... [A36559] Metformin was first approved in Canada in 1972,[A36552] and received subsequent FDA approval …
Matched Salts cas: … 1115-70-4 …
Matched Mixtures name: … BI-EUGLUCON TABLETAS LACADAS 500/2.5 MG ... ILET B GLIMEPIRIDA + METFORMINA CLORHIDRATO 2 MG+500 MG TABLETAS DE LIBERACION PROLONGADA ... BI-EUGLUCON TABLETAS LACADAS 500/5 MG …
Matched Categories: … MATE 1 Substrates ... MATE 2 Substrates ... Alimentary Tract and Metabolism ... metformin and acarbose ... metformin and gemigliptin …
Matched Products: … Metformin ER 750 mg ... Apo-metformin ER ... AURO METFORMIN 500 FILM-COATED TABLETS 500 MG BP …
Matched Synonyms: … 1,1-Dimethylbiguanide …
Matched Iupac: … 1-carbamimidamido-N,N-dimethylmethanimidamide …
Matched Description: … It is commonly described as an "insulin sensitizer", leading to a decrease in insulin resistance and ... Metformin is a biguanide antihyperglycemic agent and first-line pharmacotherapy used in the management ... [A36559] Metformin was first approved in Canada in 1972,[A36552] and received subsequent FDA approval …
Matched Salts cas: … 1115-70-4 …
Matched Mixtures name: … BI-EUGLUCON TABLETAS LACADAS 500/2.5 MG ... ILET B GLIMEPIRIDA + METFORMINA CLORHIDRATO 2 MG+500 MG TABLETAS DE LIBERACION PROLONGADA ... BI-EUGLUCON TABLETAS LACADAS 500/5 MG …
Matched Categories: … MATE 1 Substrates ... MATE 2 Substrates ... Alimentary Tract and Metabolism ... metformin and acarbose ... metformin and gemigliptin …
Matched Products: … Metformin ER 750 mg ... Apo-metformin ER ... AURO METFORMIN 500 FILM-COATED TABLETS 500 MG BP …
Black widow spider antivenin (equine)
Black widow spider (Latrodectus mactans) antivenin is a treatment for black widow spider bites derived from the serum of healthy horses immunized against black widow spider venom.
Approved
Matched Synonyms: … LATRODECTUS IMMUNE F(AB)2 …
Matched Description: … Black widow spider (_Latrodectus mactans_) antivenin is a treatment for black widow spider bites derived …
Matched Description: … Black widow spider (_Latrodectus mactans_) antivenin is a treatment for black widow spider bites derived …
Nerinetide
Na 1 is under investigation in clinical trial NCT00728182 (Evaluating Neuroprotection in Aneurysm Coiling Therapy).
Investigational
Matched Synonyms: … Na-1 ... H-TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG-LYS-LEU-SER-SER-ILE-GLU-SER-ASP-VAL-OH ... TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG-LYS-LEU-SER-SER-ILE-GLU-SER-ASP-VAL …
Matched Description: … Na 1 is under investigation in clinical trial NCT00728182 (Evaluating Neuroprotection in Aneurysm Coiling …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Matched Description: … Na 1 is under investigation in clinical trial NCT00728182 (Evaluating Neuroprotection in Aneurysm Coiling …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Atorvastatin
Atorvastatin (Lipitor®), is a lipid-lowering drug included in the statin class of medications. By inhibiting the endogenous production of cholesterol in the liver, statins lower abnormal cholesterol and lipid levels, and ultimately reduce the risk of cardiovascular disease. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,...
Approved
Matched Iupac: … (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic …
Matched Description: … Bruce Roth and approved by the FDA in 1996. ... to as "bad cholesterol"), and very-low-density lipoprotein (VLDL). ... vascular event occurring within five years) statin use leads to a 20%-22% relative reduction in the …
Matched Mixtures name: … Trinomia 100 mg/40 mg/5 mg Hartkapseln ... ATOPIR 20/75 MG KAPSUL, 30 ADET ... ATOPIR 20/75 MG KAPSUL, 90 ADET …
Matched Categories: … atorvastatin and ezetimibe ... atorvastatin and amlodipine ... atorvastatin and perindopril ... atorvastatin, amlodipine and ramipril ... atorvastatin and acetylsalicylic acid …
Matched Products: … Bio-atorvastatin ... ATORVASTATINA EG ... Sortis 5 mg Kautabletten …
Matched Description: … Bruce Roth and approved by the FDA in 1996. ... to as "bad cholesterol"), and very-low-density lipoprotein (VLDL). ... vascular event occurring within five years) statin use leads to a 20%-22% relative reduction in the …
Matched Mixtures name: … Trinomia 100 mg/40 mg/5 mg Hartkapseln ... ATOPIR 20/75 MG KAPSUL, 30 ADET ... ATOPIR 20/75 MG KAPSUL, 90 ADET …
Matched Categories: … atorvastatin and ezetimibe ... atorvastatin and amlodipine ... atorvastatin and perindopril ... atorvastatin, amlodipine and ramipril ... atorvastatin and acetylsalicylic acid …
Matched Products: … Bio-atorvastatin ... ATORVASTATINA EG ... Sortis 5 mg Kautabletten …
Displaying drugs 7776 - 7791 of 7791 in total